MANAGEMENT TEAM

about us

We are ready to answer your questions and provide guidance.

MANAGEMENT TEAM

about us

We are ready to answer your questions and provide guidance.

MANAGEMENT TEAM

Sridhar Jaligama, PhD, DABT | Deputy Division Manager of Inhalation Toxicology

 

Sridhar Jaligama, PhD, DABT, Deputy Division Manager of Inhalation Toxicology. He is a board-certified toxicologist with over 10 years of experience in the design and conduct of complex toxicology programs.  He has broad experience as a Study Director in several areas of non-clinical toxicology and with a specific expertise in inhalation and respiratory toxicology.  In this role, he has led the design and conduct of complex non-clinical toxicology studies in compliance with FDA GLP regulations.  He has led acute, subchronic, and chronic inhalation studies performed via nose-only and whole body inhalation exposure routes, and is proficient at in-depth technical reviews, data interpretation, and report preparation in compliance with the regulatory guidelines. 

In his previous roles, Dr. Jaligama has led multiple inhalation toxicology study teams in programs involving a wide range of test articles.  He is experienced in coordinating and managing toxicology research projects involving cross-functional teams.  In addition to conducting programs to meet regulatory requirements, Dr. Jaligama has led a team to develop and validate new capabilities in pulmonary function measurement; implemented a formal training program for technicians; and served as contributing scientist for several phases of GLP studies.     

Dr. Jaligama has a deep understanding of FDA Tobacco Deeming Regulations and Pre-market Tobacco Application requirements, and has served as the single point of technical contact for large toxicology programs conducted in support of Pre-market Tobacco Applications to FDA. He is an author/co-author of more than 50 publications and posters/presentations.

 

To Learn More About IITRI